US2010136426A1PendingUtilityA1
Resistance-stabilizing additives for electrolyte
Est. expiryJan 31, 2026(expired)· nominal 20-yr term from priority
H01M 10/0567Y02E60/10
55
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A resistance-stabilizing additive to an electrolyte for a battery cell in an implantable medical device is presented. At least one resistance-stabilizing additive is selected from a group comprising an electron withdrawing group, an aromatic diacid salt, an inorganic salt, an aliphatic organic acid, an aromatic diacid, and an aromatic monoacid.
Claims
exact text as granted — not AI-modified1 . A resistance-stabilizing additive for an electrolyte of a battery cell in an implantable medical device (IMD) comprising:
at least one chemical compound selected from a chemical class consisting of an electron withdrawing group, an aromatic diacid salt, an inorganic salt, an aliphatic organic acid, an aromatic diacid, and an aromatic monoacid.
2 . The additive of claim 1 wherein the electron-withdrawing group selected from one of trifluoromethylvinyl acetate and 2,2,2-trifluoroacetamide.
3 . The additive of claim 1 , wherein aromatic monoacid comprises benzoic acid.
4 . The additive of claim 1 , wherein the benzoic acid includes fluorinated benzoic acid.
5 . The additive of claim 1 , wherein the benzoic acid being one of 3-hydroxy benzoic acid and 2-4 hydroxy benzoic acid.
6 . The additive of claim 1 , wherein the organic acid selected from a group comprising carboxylic acid, benzoic acid, and hexafluoroglutaric acid.
7 . An additive to an electrolyte for use in a battery cell in an IMD, the additive comprising:
an electron-withdrawing group.
8 . The additive of claim 6 wherein the electron-withdrawing group selected from one of trifluoromethylvinyl acetate and 2,2,2-trifluoroacetamide.
9 . An additive to an electrolyte for use in a battery cell in an IMD, the additive being at least one of tetramethyl ammonium (TMA) hydrogen phthalate, tetrabutyl-ammonium (TBA) hydrogen sulfate, phosphonoacetic acid, 2,2,2-trifluoroacetamide, trifluoromethyl vinyl acetate, phthalic acid, benzoylacetone, benzoltrifluoroactone, and benzoic acid.
10 . An additive composition for an electrolyte in a battery cell for an IMD comprising:
a first resistance-stabilizing additive; and a second resistance-stabilizing additive combined with the first resistance-stabilizing additive.
11 . The additive composition of claim 10 , the first resistance-stabilizing additive being at least one of TMA hydrogen phthalate, TBA hydrogen sulfate, phosphonoacetic acid, 2,2,2-trifluoroacetamide, trifluoromethyl vinyl acetate, phthalic acid, benzoylacetone, benzoltrifluoroactone, and benzoic acid.
12 . The additive composition of claim 10 , the second resistance-stabilizing additive being at least one of TMA hydrogen phthalate, TBA hydrogen sulfate, phosphonoacetic acid, 2,2,2-trifluoroacetamide, trifluoromethyl vinyl acetate, phthalic acid, benzoylacetone, benzoltrifluoroactone, and benzoic acid.
13 . The additive composition of claim 10 , further comprising:
a third resistance-stabilizing additive, the third resistance-stabilizing additive being at least one of TMA hydrogen phthalate, TBA hydrogen sulfate, phosphonoacetic acid, 2,2,2-trifluoroacetamide, trifluoromethyl vinyl acetate, phthalic acid, benzoylacetone, benzoltrifluoroactone, and benzoic acid.
14 . A method for forming an additive composition for an electrolyte in a battery cell for an IMD, the method comprising:
selecting a first resistance-stabilizing additive; and combining a second resistance-stabilizing additive with the first resistance-stabilizing additive to form a resistance-stabilizing composition.
15 . The method of claim 14 , further comprising:
combining the resistance-stabilizing composition with a base electrolyte composition for the battery cell.
16 . The method of claim 14 , the first resistance-stabilizing additive being at least one of TMA hydrogen phthalate, TBA hydrogen sulfate, phosphonoacetic acid, 2,2,2-trifluoroacetamide, trifluoromethyl vinyl acetate, phthalic acid, benzoylacetone, benzoltrifluoroactone, and benzoic acid.
17 . The method of claim 14 , the second resistance-stabilizing additive being at least one of TMA hydrogen phthalate, TBA hydrogen sulfate, phosphonoacetic acid, 2,2,2-trifluoroacetamide, trifluoromethyl vinyl acetate, phthalic acid, benzoylacetone, benzoltrifluoroactone, and benzoic acid.
18 . An electrolyte comprising a base liquid electrolyte composition and a resistance-stabilizing additive distinct from the base liquid electrolyte composition, wherein the resistance-stabilizing additive comprises at least one chemical compound selected from a chemical class consisting of a compound comprising an electron withdrawing group, an aromatic diacid salt, an inorganic salt, an aliphatic organic acid, an aromatic diacid, and an aromatic monoacid.
19 . The electrolyte of claim 18 , wherein the resistance-stabilizing additive comprises a compound comprising an electron-withdrawing group that is selected from one of trifluoromethylvinyl acetate and 2,2,2-trifluoroacetamide.
20 . The electrolyte of claim 18 , wherein the resistance-stabilizing additive comprises an aromatic monoacid that comprises a benzoic acid.
21 . The electrolyte of claim 20 , wherein the benzoic acid includes fluorinated benzoic acid.
22 . The electrolyte of claim 20 , wherein the benzoic acid is selected from one of 3-hydroxy benzoic acid and 2-4 hydroxy benzoic acid.
23 . The electrolyte of claim 18 , wherein the resistance-stabilizing additive comprises an organic acid that is selected from a group comprising carboxylic acid, benzoic acid, and hexafluoroglutaric acid.
24 . An electrolyte comprising a base liquid electrolyte composition and a resistance-stabilizing additive distinct from the base liquid electrolyte composition, wherein the resistance-stabilizing additive comprises a compound having an electron-withdrawing group.
25 . The electrolyte of claim 24 , wherein the compound having an electron-withdrawing group comprises 2,2,2-trifluoroacetamide.
26 . An electrolyte comprising a base liquid electrolyte composition and a resistance-stabilizing additive distinct from the base liquid electrolyte composition, wherein the resistance-stabilizing additive comprises at least one of tetramethyl ammonium (TMA) hydrogen phthalate, tetrabutyl-ammonium (TBA) hydrogen sulfate, phosphonoacetic acid, 2,2,2-trifluoroacetamide, trifluoromethyl vinyl acetate, phthalic acid, benzoylacetone, benzoyltrifluoroacetone, and benzoic acid.
27 . An electrolyte comprising:
a base liquid electrolyte composition; a first resistance-stabilizing additive; and a second resistance-stabilizing additive combined with the first resistance-stabilizing additive; wherein the first and second resistance-stabilizing additives are distinct from the base liquid electrolyte composition.
28 . The electrolyte of claim 27 , the first resistance-stabilizing additive being at least one of TMA hydrogen phthalate, TBA hydrogen sulfate, phosphonoacetic acid, 2,2,2-trifluoroacetamide, trifluoromethyl vinyl acetate, phthalic acid, benzoylacetone, benzoyltrifluoroacetone, and benzoic acid.
29 . The electrolyte of claim 27 , the second resistance-stabilizing additive being at least one of TMA hydrogen phthalate, TBA hydrogen sulfate, phosphonoacetic acid, 2,2,2-trifluoroacetamide, trifluoromethyl vinyl acetate, phthalic acid, benzoylacetone, benzoyltrifluoroacetone, and benzoic acid.
30 . The electrolyte of claim 27 , further comprising:
a third resistance-stabilizing additive, the third resistance-stabilizing additive being at least one of TMA hydrogen phthalate, TBA hydrogen sulfate, phosphonoacetic acid, 2,2,2-trifluoroacetamide, trifluoromethyl vinyl acetate, phthalic acid, benzoylacetone, benzoyltrifluoroacetone, and benzoic acid.
31 . A method for forming an electrolyte in a battery cell for an implantable medical device, the method comprising:
selecting a first resistance-stabilizing additive; combining a second resistance-stabilizing additive with the first resistance-stabilizing additive to form a resistance-stabilizing composition; and combining the resistance-stabilizing composition with a base electrolyte composition for the battery cell.
32 . The method of claim 31 , the first resistance-stabilizing additive being at least one of TMA hydrogen phthalate, TBA hydrogen sulfate, phosphonoacetic acid, 2,2,2-trifluoroacetamide, trifluoromethyl vinyl acetate, phthalic acid, benzoylacetone, benzoyltrifluoroacetone, and benzoic acid.
33 . The method of claim 31 , the second resistance-stabilizing additive being at least one of TMA hydrogen phthalate, TBA hydrogen sulfate, phosphonoacetic acid, 2,2,2-trifluoroacetamide, trifluoromethyl vinyl acetate, phthalic acid, benzoylacetone, benzoyltrifluoroacetone, and benzoic acid.
34 . A battery comprising an electrode assembly and an electrolyte, wherein the electrolyte comprises a liquid electrolyte and a resistance-stabilizing additive distinct from the liquid electrolyte, wherein the resistance-stabilizing additive comprises at least one chemical compound selected from a compound comprising an electron withdrawing group, an aromatic diacid salt, an inorganic salt, an aliphatic organic acid, an aromatic diacid, an aromatic monoacid, and combinations thereof.
35 . The battery of claim 34 , wherein the resistance-stabilizing additive comprises compound comprising an electron-withdrawing group.
36 . An implantable medical device comprising the battery of claim 34 .
37 . A battery comprising an electrode assembly and an electrolyte, wherein the electrolyte comprises a liquid electrolyte and a resistance-stabilizing additive distinct from the liquid electrolyte, the additive being at least one of TMA hydrogen phthalate, TBA hydrogen sulfate, phosphonoacetic acid, 2,2,2-trifluoroacetamide, trifluoromethyl vinyl acetate, phthalic acid, benzoylacetone, benzoyltrifluoroacetone, and benzoic acid.
38 . An implantable medical device comprising the battery of claim 37 .
39 . A battery comprising an electrode assembly and an electrolyte, wherein the electrolyte comprises a liquid electrolyte and a resistance-stabilizing additive composition distinct from the liquid electrolyte, the additive composition comprising:
a first resistance-stabilizing additive; and a second resistance-stabilizing additive combined with the first resistance-stabilizing additive.
40 . An implantable medical device comprising the battery of claim 39 .Join the waitlist — get patent alerts
Track US2010136426A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.